FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Synageva BioPharma Announces A 2.5 Million Share Proposed Public Offering Of Its Common Stock
January 05, 2015
Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA
December 23, 2014
Synageva BioPharma To Present At The 33rd Annual J.P. Morgan Healthcare Conference On Monday, January 12, 2015 at 9:00 a.m. PST
December 17, 2014
Synageva BioPharma Announces Active Investigational New Drug Application For SBC-103 For The Treatment Of Mucopolysaccharidosis IIIB
December 15, 2014
Synageva BioPharma Announces Dosing Of Patients Commenced With SBC-103 In Phase 1/2 Study For Mucopolysaccharidosis IIIB And FDA Fast Track Designation Granted
Today 7:31 EST
Use Options For a Chance To Buy GEVA at a 25% Discount
January 08, 2015
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here